A series of humanoid-related announcements dominated our most popular articles in December 2024.
Microbot Medical submits LIBERTY surgical robot to FDA for approval
Microbot Medical said LIBERTY eliminates the need for large and expensive equipment and streamlines customers’ access to robotics.
Microbot Medical completes 1st clinical trial of surgical robot
The Liberty surgical robot is a single-use endovascular system and requires no dedicated infrastructure to be used.
Microbot Medical expands U.S. operations to prep for first in-human clinical study
Microbot Medical is adding a U.S.-based clinical research associate to support its IDE submission to commence its first-in-human clinical trial.
Microbot Medical is a step closer to an FDA IDE submission
Microbot Medical has completed a pivotal pre-clinical study of its Liberty endovascular robotic surgical system.
Microbot Medical raises $9M for disposable medical robot
Microbot Medical raised nearly $9 million in a common stock offering. This comes just days after announcing it is set to unveil its disposable robotic system for multiple procedures later this month. The Hingham, Mass.–based company agreed to sell 900,901 shares of common stock at a purchase price of $11.10 per share. The gross proceeds…